卡他唑酯

化合物

卡他唑酯(英语:Cartazolate,开发代号:SQ-65,396)是一种吡唑并吡啶类药物。它作为复合物巴比妥结合位点GABAA受体正向变构调节剂,对动物具有抗焦虑作用。[1][2][3][4]它还可作为A1A2亚型的腺苷拮抗剂以及磷酸二酯酶抑制剂[5][6]卡他唑酯经过人体临床试验,发现对焦虑症有效,但从未上市。[7]它是由E.R. Squibb and Sons的团队于1970年代开发的。[8]

卡他唑酯
臨床資料
给药途径口服
ATC碼
  • 未分配
法律規範狀態
法律規範
  • 不受管制
识别信息
  • Уthyl 4-(butylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
CAS号34966-41-1
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
化学信息
化学式C15H22N4O2
摩尔质量290.37 g·mol−1
3D模型(JSmol英语JSmol
  • O=C(C1=CN=C(N(CC)N=C2)C2=C1NCCCC)OCC

参见

编辑

参考资料

编辑
  1. ^ Placheta P, Karobath M. In vitro modulation by SQ 20009 and SQ 65396 of GABA receptor binding in rat CNS membranes. European Journal of Pharmacology. March 1980, 62 (2–3): 225–8. PMID 6103810. doi:10.1016/0014-2999(80)90281-2. 
  2. ^ Supavilai P, Karobath M. Action of pyrazolopyridines as modulators of [3H]flunitrazepam binding to the gaba/benzodiazepine receptor complex of the cerebellum. European Journal of Pharmacology. March 1981, 70 (2): 183–93. PMID 6114867. doi:10.1016/0014-2999(81)90213-2. 
  3. ^ Leeb-Lundberg F, Snowman A, Olsen RW. Perturbation of benzodiazepine receptor binding by pyrazolopyridines involves picrotoxinin/barbiturate receptor sites. Journal of Neuroscience. May 1981, 1 (5): 471–7. PMC 6564167 . PMID 7050308. doi:10.1523/JNEUROSCI.01-05-00471.1981 . 
  4. ^ Bristow DR, Martin IL. Biochemical characterization of an isolated and functionally reconstituted gamma-aminobutyric acid/benzodiazepine receptor. Journal of Neurochemistry. March 1990, 54 (3): 751–61. PMID 2154549. S2CID 25784613. doi:10.1111/j.1471-4159.1990.tb02315.x. 
  5. ^ Daly JW, Hong O, Padgett WL, Shamim MT, Jacobson KA, Ukena D. Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors. Biochemical Pharmacology. February 1988, 37 (4): 655–64. PMC 3445624 . PMID 2829919. doi:10.1016/0006-2952(88)90139-6. 
  6. ^ Wachtel H. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors. Psychopharmacology. 1982, 77 (4): 309–16. PMID 6182575. S2CID 10122417. doi:10.1007/BF00432761. 
  7. ^ O'Brien, Robert. Receptor binding in drug research. New York: Dekker. 1986: 519. ISBN 0-8247-7548-1. 
  8. ^ US 3966746,Hoehn, Hans & Theodor Denzel,「Amino derivatives of pyrazolopyridine carboxamides」,发表于1976-06-29